Shenzhen Weiguang Biological Products Co., Ltd.
SZSE:002880.SZ
33.35 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 252.3 | 294.587 | 332.104 | 471.469 | 304.606 | 260.32 | 338.972 | 61.91 | 119.229 | 113.536 | 70.379 | 139.944 |
| Short Term Investments
| -658.038 | -183.51 | -23.53 | -4.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 252.3 | 294.587 | 332.104 | 471.469 | 304.606 | 260.32 | 338.972 | 61.91 | 119.229 | 113.536 | 70.379 | 139.944 |
| Net Receivables
| 141.114 | 225.406 | 213.078 | 252.781 | 236.531 | 168.42 | 97.423 | 16.019 | 9.245 | 9.535 | 12.293 | 8.581 |
| Inventory
| 672.983 | 605.51 | 421.676 | 383.921 | 467.723 | 495.993 | 447.821 | 361.624 | 276.597 | 245.511 | 229.613 | 153.096 |
| Other Current Assets
| 37.308 | 7.62 | 32.5 | 13.521 | -0.707 | 0.329 | 0.101 | -0.411 | -0.722 | -0.713 | -0.239 | -0.466 |
| Total Current Assets
| 1,103.705 | 1,133.124 | 999.358 | 1,121.692 | 1,008.154 | 925.062 | 884.317 | 439.141 | 404.349 | 367.869 | 312.047 | 301.155 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 683.185 | 1,044.876 | 785.217 | 565.299 | 447.865 | 424.267 | 392.755 | 374.016 | 352.796 | 303.217 | 319.18 | 281.817 |
| Goodwill
| 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 | 19.23 |
| Intangible Assets
| 158.362 | 94.754 | 90.955 | 93.232 | 93.434 | 86.327 | 74.99 | 75.245 | 77.234 | 77.198 | 61.247 | 62.058 |
| Goodwill and Intangible Assets
| 177.592 | 113.984 | 110.185 | 112.462 | 112.664 | 105.557 | 94.22 | 94.475 | 96.464 | 96.428 | 80.477 | 81.288 |
| Long Term Investments
| 744.758 | 267.003 | 92.697 | 23.2 | 4.95 | 0 | -3.38 | -2.247 | -2.356 | 0 | 0 | 0 |
| Tax Assets
| 10.543 | 2.508 | 3.074 | 3.168 | 3.573 | 4.434 | 3.38 | 2.247 | 2.356 | 2.077 | 1.088 | 1.373 |
| Other Non-Current Assets
| 156.996 | 14.24 | 12.974 | 10.323 | 8.189 | 0 | 3.38 | 2.247 | 2.356 | 0 | 0 | 0 |
| Total Non-Current Assets
| 1,773.074 | 1,442.61 | 1,004.147 | 714.452 | 577.242 | 534.257 | 490.355 | 470.739 | 451.616 | 401.723 | 400.745 | 364.478 |
| Total Assets
| 2,876.779 | 2,575.734 | 2,003.505 | 1,836.144 | 1,585.396 | 1,459.32 | 1,374.672 | 909.88 | 855.965 | 769.592 | 712.792 | 665.633 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 77.545 | 33.145 | 28.975 | 24.102 | 19.975 | 16.27 | 9.617 | 6.794 | 8.236 | 8.631 | 12.216 | 9.087 |
| Short Term Debt
| 25.611 | 101.402 | 26.386 | 82 | -1.438 | 29 | 46 | 218.825 | 266.5 | 315.7 | 267.5 | 205 |
| Tax Payables
| 18.726 | 13.429 | 23.365 | 13.046 | 12.332 | 12.957 | 10.207 | 6.539 | 4.131 | 4.949 | 5.73 | 3.657 |
| Deferred Revenue
| 162.707 | 7.81 | 111.76 | 78.359 | 1.438 | 12.957 | 50.089 | 46.217 | 34.163 | 37.334 | 39.821 | 138.892 |
| Other Current Liabilities
| 0.126 | 87.399 | 0.034 | 0.032 | 83.083 | 57.272 | 0.675 | 1.604 | 1.079 | 2.441 | 1.551 | 29.472 |
| Total Current Liabilities
| 265.989 | 229.756 | 167.155 | 184.493 | 103.059 | 115.499 | 106.381 | 273.441 | 309.978 | 364.106 | 321.088 | 382.451 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 499.787 | 445.621 | 17.037 | 0 | 0 | 0 | 24 | 76 | 96.875 | 39.375 | 111.875 | 90 |
| Deferred Revenue Non-Current
| 46.775 | 25.915 | 23.981 | 25.818 | 31.53 | 38.036 | 41.144 | 53.997 | 55.398 | 57.25 | 55.946 | 48.602 |
| Deferred Tax Liabilities Non-Current
| 12.536 | 0.856 | 1.008 | 0 | 0 | 0 | -24 | -76 | -96.875 | -39.375 | -111.875 | -80.423 |
| Other Non-Current Liabilities
| 6.051 | 6.052 | 6.05 | 2.05 | 2.05 | 0 | 24 | 76 | 96.875 | 39.375 | 111.875 | 90 |
| Total Non-Current Liabilities
| 565.15 | 478.444 | 48.075 | 27.868 | 33.58 | 38.036 | 65.144 | 129.997 | 152.273 | 96.625 | 167.821 | 148.179 |
| Total Liabilities
| 831.14 | 708.2 | 215.23 | 212.361 | 136.639 | 153.535 | 171.524 | 403.438 | 462.251 | 460.731 | 488.909 | 530.63 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 226.8 | 226.8 | 226.8 | 162 | 108 | 108 | 108 | 81 | 81 | 81 | 81 | 81 |
| Retained Earnings
| 1,042.908 | 891.448 | 832.203 | 688.137 | 605.214 | 480.093 | 392.823 | 334.598 | 237.15 | 164.594 | 89.532 | 9.298 |
| Accumulated Other Comprehensive Income/Loss
| 170.068 | 148.059 | 135.22 | 114.349 | 95.434 | 78.709 | 63.023 | 90.844 | 75.565 | 0 | -0 | 0 |
| Other Total Stockholders Equity
| 574.502 | 574.502 | 574.502 | 639.302 | 639.302 | 638.982 | 639.302 | 0 | 0 | 63.267 | 53.352 | 44.705 |
| Total Shareholders Equity
| 2,014.278 | 1,840.809 | 1,768.725 | 1,603.789 | 1,447.95 | 1,305.785 | 1,203.148 | 506.442 | 393.715 | 308.861 | 223.883 | 135.003 |
| Total Equity
| 2,045.639 | 1,867.534 | 1,788.275 | 1,623.783 | 1,448.757 | 1,305.785 | 1,203.148 | 506.442 | 393.715 | 308.861 | 223.883 | 135.003 |
| Total Liabilities & Shareholders Equity
| 2,876.779 | 2,575.734 | 2,003.505 | 1,836.144 | 1,585.396 | 1,459.32 | 1,374.672 | 909.88 | 855.965 | 769.592 | 712.792 | 665.633 |